Drug Approval | July 24, 2025
Lupin receives USFDA approvals for Liraglutide and Glucagon injectable products
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
_256_384.jpg)
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Based on the CRL, the STARGLO data do not provide sufficient evidence to support the proposed second-line DLBCL indication in the US patient population
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Subscribe To Our Newsletter & Stay Updated
